US Patent Application No: 2008/0287,428

Number of patents in Portfolio can not be more than 2000

Novel Heterocyclidene Acetamide Derivative

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A compound represented by formula (I'): (wherein m, n, and p each represent 0 to 2; q represents 0 or 1; R.sup.1 represents halogen, a hydrocarbon group, a heterocyclic group, an alkoxy group, an alkoxycarbonyl group, a sulfamoyl group, a CN group, an NO.sub.2 group, or the like; R.sup.2 represents halogen, amino, a hydrocarbon group, an aromatic heterocyclic group, or an oxo group; X.sub.1 represents O, --NR.sup.3--, or --S(O)r-; X.sub.2 represents a methylene group, O, --NR.sup.3--, or --S(O)r-; Q' represents a heteroaryl group, a heteroarylalkyl group, a substituted aryl group, or an aralkyl group; Cycle moiety represents an aryl ring or a heteroaryl ring; and the wavy line represents an E-isomer or a Z-isomer), a salt of the compound, or a solvate of the compound or the salt. A pharmaceutical composition and a transient receptor potential type I (TRPV1) receptor antagonist each contain, as an active ingredient, at least one of the compound, a salt of the compound, and a solvate of the compound or the salt.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
MOCHIDA PHARMACEUTICAL CO., LTD.TOKYO58

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Akada, Yasushige Tokyo, JP 5 38
Amano, Ken-ichi Tokyo, JP 2 6
Hotta, Daido Tokyo, JP 3 15
Kamino, Tomoyuki Tokyo, JP 4 6
Kosuga, Naoto Tokyo, JP 3 15
Maeda, Yoshitaka Tokyo, JP 7 11
Satoh, Tsutomu Tokyo, JP 42 571
Uchida, Hideharu Tokyo, JP 3 11

Cited Art Landscape

Patent Info (Count) # Cites Year
 
PHARMACIA ITALIA S.P.A. (1)
* 2004/0204,477 Interaction inhibitors of tcf-4 with beta-catenin 13 2004
 
YAMANOUCHI PHARMACEUTICAL CO., LTD. (1)
* 5,710,150 Benzazepine derivative, pharmaceutical composition thereof, and intermediate thereof 8 1996
 
JAPAN TOBACCO INC. (1)
* 2006/0035,882 CONDENSED BENZAMIDE COMPOUNDS AND INHIBITORS OF VANILLOID RECEPTOR SUBTYPE 1 (VR1) ACTIVITY 12 2005
 
EASTMAN KODAK COMPANY (1)
* 6,120,964 2-(1,2-benzisothiazol-3(2H)-ylidene 1,1-dioxide)acetamides negative charge control agents for electrostatographic toners and developers 2 1999
 
Rhone-Poulenc Sante (1)
* 4,977,166 Benzopyran derivatives and pharmaceutical compositions containing them 12 1989
 
AMGEN INC. (1)
* 2004/0038,969 Vanilloid receptor ligands and their use in treatments 3 2003
 
ASTELLAS PHARMA INC. (3)
* 6,340,678 4,4-difluoro-2,3,4,5-tetrahydro-1H-1-benzoazepine derivatives and drug compositions containing them 21 1999
* 2005/0004,103 4,4-Difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivatives or salts thereof 5 2002
* 2007/0167,444 Benzamide derivative or salt thereof 20 2004
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
GLENMARK PHARMACEUTICALS S.A. (2)
* 8,492,568 Chromane derivatives as TRPV3 modulators 0 2009
* 2011/0098,316 CHROMANE DERIVATIVES AS TRPV3 MODULATORS 0 2009
 
MOCHIDA PHARMACEUTICAL CO., LTD. (2)
7,910,751 Heterocyclidene acetamide derivative 4 2006
* 2010/0016,285 HETEROCYCLIDENE-N-(ARYL) ACETAMIDE DERIVATIVE 5 2009
* Cited By Examiner